Search

everythinglearnresearchcommunity

for

Search:↓

The Swedish neonatal screening program effectively detects PKU, galactosaemia, and biotinidase deficiency with low false positives.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, which could be a new target for treating hair loss and other skin conditions driven by testosterone.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Steroid sulfatase in hair follicles may be a target for treating hair loss.

The process effectively regenerates the Pd/C catalyst for finasteride synthesis.

CCC1 is essential for ion balance and proper plant cell function.

Targeting protein S-palmitoylation could lead to new skin disease treatments.

Researchers found a specific T cell receptor linked to severe drug reactions like Stevens-Johnson syndrome when patients take carbamazepine.

A TNFAIP3 gene mutation can cause unusual and varied symptoms of lupus and Sjogren's syndrome.

TTD patients don't have a higher skin cancer risk because their main issue is with transcription, not DNA repair.

5α-reductases increase epitestosterone's effect on androgen receptors.

GI197111X is best dissolved in Capmul MCM for trials.

Phosphorylation controls TFEB's location in the cell, affecting cell metabolism and stress response.

The method effectively detects MeT and TP in dried blood spots after cream application.

Tanning ability is linked to specific DNA changes in skin genes.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Heart-specific steroid metabolism is crucial in cardiac hypertrophy.

Both HPSAM and PLS methods accurately measure minoxidil and tretinoin concentrations.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

About 41% of Indian hair loss patients have low enzyme activity that affects hair loss treatment effectiveness, with men affected more than women. Testing for this can guide treatment.

The NUDT15 R139C variant causes thiopurine-induced leukocytopenia through a different mechanism than previously thought in Japanese patients with inflammatory bowel disease.

Thujae occidentalis semen extract may help treat male pattern baldness by blocking a hair loss-related enzyme and reducing hair loss in mice.

Using laccase to add poly(tyrosine) to wool makes it less likely to shrink and stronger.

A new MBTPS2 gene variant disrupts fat metabolism and collagen production, causing Osteogenesis imperfecta.

The fer-ts mutation in plants prevents root hair growth at high temperatures.

Reduced TRPS1 leads to increased STAT3 and SOX9 in hair follicles, affecting hair growth.

A woman's severe skin reaction was caused by an allergy to a skin treatment.